FIVE-DAY-OLD Andrew Gobea became the first newborn to undergo gene therapy when surgeons at a Los Angeles hospital injected him recently with gene-altered cells obtained from his mother's placental blood to cure a usually fatal defect in his immune system. Andrew suffers from bubbly bay disease and lacks an enzyme that's essential to fight infection.
Andrew is reported in good condition, but it may take six months to know if the experiment was a success. Until then, he will be kept in a germ-free plastic bubble. Hospital officials say they hope the gene therapy programme will eventually lead to in-the-womb treatment of such diseases as AIDS, haemophilia and sickle cell anaemia.
We are a voice to you; you have been a support to us. Together we build journalism that is independent, credible and fearless. You can further help us by making a donation. This will mean a lot for our ability to bring you news, perspectives and analysis from the ground so that we can make change together.
Comments are moderated and will be published only after the site moderator’s approval. Please use a genuine email ID and provide your name. Selected comments may also be used in the ‘Letters’ section of the Down To Earth print edition.